Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Ho Moon

Showing results (81-90 of 305) with videos related to

Pageof 31
Sort By:
Blood Research|August 21, 2025
Real-world data on long-term outcomes in patients with T-cell lymphomas: a nationwide study of KoreaDong Won Baek, Jung Min Lee, Youngeun Jang, et al.
The Journal of Reproduction and Development|June 11, 2013
Effect of 7,8-dihydroxyflavone as an antioxidant on in vitro maturation of oocytes and development of parthenogenetic embryos in pigsJi-Yei Choi, Jung-Taek Kang, Sol-Ji Park, et al.
Blood Research|November 16, 2019
Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type <i>NPM1</i> without <i>FLT3</i>-ITDDong Won Baek, Jung Min Lee, Ju-Hyung Kim, et al.
Leukemia & Lymphoma|August 19, 2007
Efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistanceSang Kyun Sohn, Joon Ho Moon, Yoon Young Cho, et al.
Annals of Hematology|September 28, 2011
Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blastJoon Ho Moon, Soo Jung Lee, Yoo Jin Lee, et al.
Annals of Hematology|November 19, 2009
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II studyYeo-Kyeoung Kim, Sang-Kyun Sohn, Jae-Hoon Lee, et al.
Scientific Reports|December 7, 2018
Generation of a highly efficient and tissue-specific tryptophan hydroxylase 1 knockout mouse modelHyeongseok Kim, Yeong Gi Kim, Wonsuk Choi, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2009
Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOPYee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, et al.
Journal of Infection and Public Health|May 15, 2020
COVID-19 transmission and blood transfusion: A case reportHee Jeong Cho, Ji Wan Koo, Soong Ki Roh, et al.
Frontiers in Oncology|May 8, 2024
Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic eraDong Won Baek, Ga-Young Song, Ho Sup Lee, et al.
Pageof 31

Showing results (81-90 of 305) with videos related to

Sort By:
Pageof 31
Blood Research|August 21, 2025
Real-world data on long-term outcomes in patients with T-cell lymphomas: a nationwide study of KoreaDong Won Baek, Jung Min Lee, Youngeun Jang, et al.
The Journal of Reproduction and Development|June 11, 2013
Effect of 7,8-dihydroxyflavone as an antioxidant on in vitro maturation of oocytes and development of parthenogenetic embryos in pigsJi-Yei Choi, Jung-Taek Kang, Sol-Ji Park, et al.
Blood Research|November 16, 2019
Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type <i>NPM1</i> without <i>FLT3</i>-ITDDong Won Baek, Jung Min Lee, Ju-Hyung Kim, et al.
Leukemia & Lymphoma|August 19, 2007
Efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistanceSang Kyun Sohn, Joon Ho Moon, Yoon Young Cho, et al.
Annals of Hematology|September 28, 2011
Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blastJoon Ho Moon, Soo Jung Lee, Yoo Jin Lee, et al.
Annals of Hematology|November 19, 2009
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II studyYeo-Kyeoung Kim, Sang-Kyun Sohn, Jae-Hoon Lee, et al.
Scientific Reports|December 7, 2018
Generation of a highly efficient and tissue-specific tryptophan hydroxylase 1 knockout mouse modelHyeongseok Kim, Yeong Gi Kim, Wonsuk Choi, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2009
Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOPYee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, et al.
Journal of Infection and Public Health|May 15, 2020
COVID-19 transmission and blood transfusion: A case reportHee Jeong Cho, Ji Wan Koo, Soong Ki Roh, et al.
Frontiers in Oncology|May 8, 2024
Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic eraDong Won Baek, Ga-Young Song, Ho Sup Lee, et al.
Pageof 31